{"transactions":[{"id":940459,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Flowers Cynthia Louise","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:04:26.000Z","date":"2026-01-09","kind":"grant","planned":false,"acquired":true,"shares":30456,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 30,456 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 9, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 30,456 unvested restricted stock units."}],"balance_after":95446,"source":{"system":"sec-edgar","filing":"0001741455-26-000003","document":"wk-form4_1768338264.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000174145526000003/wk-form4_1768338264.xml","form_type":"4"}},{"id":1304646,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Flowers Cynthia Louise","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-13T21:03:49.000Z","date":"2025-01-09","kind":"grant","planned":false,"acquired":true,"shares":15789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 15,789 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 9, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 15,789 unvested restricted stock units."}],"balance_after":64990,"source":{"system":"sec-edgar","filing":"0001741455-25-000002","document":"wk-form4_1736802222.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000174145525000002/wk-form4_1736802222.xml","form_type":"4"}},{"id":1403245,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Flowers Cynthia Louise","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-18T16:15:17.000Z","date":"2024-09-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each \"Stock Option\") that was outstanding immediately prior to the Effective Time became fully vested and was cancelled at the Effective Time and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of common stock subject to such Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Merger Consideration over the applicable exercise price per share under such Stock Option."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each \"Stock Option\") that was outstanding immediately prior to the Effective Time became fully vested and was cancelled at the Effective Time and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of common stock subject to such Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Merger Consideration over the applicable exercise price per share under such Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each \"Stock Option\") that was outstanding immediately prior to the Effective Time became fully vested and was cancelled at the Effective Time and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of common stock subject to such Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Merger Consideration over the applicable exercise price per share under such Stock Option."}],"balance_after":0,"derivative":{"exercise_price":5.3,"expiration_date":"2032-06-23","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950170-24-107798","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000095017024107798/ownership.xml","form_type":"4"}},{"id":1403244,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Flowers Cynthia Louise","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-18T16:15:17.000Z","date":"2024-09-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each \"Stock Option\") that was outstanding immediately prior to the Effective Time became fully vested and was cancelled at the Effective Time and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of common stock subject to such Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Merger Consideration over the applicable exercise price per share under such Stock Option."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each \"Stock Option\") that was outstanding immediately prior to the Effective Time became fully vested and was cancelled at the Effective Time and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of common stock subject to such Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Merger Consideration over the applicable exercise price per share under such Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each \"Stock Option\") that was outstanding immediately prior to the Effective Time became fully vested and was cancelled at the Effective Time and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of common stock subject to such Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Merger Consideration over the applicable exercise price per share under such Stock Option."}],"balance_after":0,"derivative":{"exercise_price":2.83,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950170-24-107798","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000095017024107798/ownership.xml","form_type":"4"}},{"id":1403243,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Flowers Cynthia Louise","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-18T16:15:17.000Z","date":"2024-09-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each \"Stock Option\") that was outstanding immediately prior to the Effective Time became fully vested and was cancelled at the Effective Time and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of common stock subject to such Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Merger Consideration over the applicable exercise price per share under such Stock Option."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each \"Stock Option\") that was outstanding immediately prior to the Effective Time became fully vested and was cancelled at the Effective Time and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of common stock subject to such Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Merger Consideration over the applicable exercise price per share under such Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each \"Stock Option\") that was outstanding immediately prior to the Effective Time became fully vested and was cancelled at the Effective Time and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of common stock subject to such Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Merger Consideration over the applicable exercise price per share under such Stock Option."}],"balance_after":0,"derivative":{"exercise_price":2.99,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950170-24-107798","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000095017024107798/ownership.xml","form_type":"4"}},{"id":1403242,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Flowers Cynthia Louise","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-18T16:15:17.000Z","date":"2024-09-18","kind":"other","planned":false,"acquired":false,"shares":15889,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each share of common stock held by the Reporting Person was tendered in exchange for the Merger Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each share of common stock held by the Reporting Person was tendered in exchange for the Merger Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-107798","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000095017024107798/ownership.xml","form_type":"4"}},{"id":1403241,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Flowers Cynthia Louise","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-18T16:15:17.000Z","date":"2024-09-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of that certain Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of August 6, 2024, among the Issuer, Pharmacosmos A/S, a Danish Aktieselskab (\"Parent\"), and Genesis Merger Sub, Inc. (\"Purchaser\"), an indirect wholly-owned subsidiary of Parent, Purchaser completed a tender offer for shares of common stock of the Issuer and thereafter merged with and into the Issuer (the \"Merger\"), effective as of September 18, 2024, with the Issuer surviving the Merger. At the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer common stock was cancelled and converted into the right to receive $7.15 per share in cash, without interest and subject to any applicable withholding taxes (the \"Merger Consideration\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from footnote 1) Pursuant to the Merger Agreement, at the Effective Time, each outstanding deferred stock unit (whether vested or unvested) was deemed to have vested and was cancelled and automatically converted into the right to receive an amount in cash equal to the Merger Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of that certain Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of August 6, 2024, among the Issuer, Pharmacosmos A/S, a Danish Aktieselskab (\"Parent\"), and Genesis Merger Sub, Inc. (\"Purchaser\"), an indirect wholly-owned subsidiary of Parent, Purchaser completed a tender offer for shares of common stock of the Issuer and thereafter merged with and into the Issuer (the \"Merger\"), effective as of September 18, 2024, with the Issuer surviving the Merger. At the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer common stock was cancelled and converted into the right to receive $7.15 per share in cash, without interest and subject to any applicable withholding taxes (the \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from footnote 1) Pursuant to the Merger Agreement, at the Effective Time, each outstanding deferred stock unit (whether vested or unvested) was deemed to have vested and was cancelled and automatically converted into the right to receive an amount in cash equal to the Merger Consideration."}],"balance_after":15889,"source":{"system":"sec-edgar","filing":"0000950170-24-107798","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000095017024107798/ownership.xml","form_type":"4"}},{"id":1478553,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Flowers Cynthia Louise","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2024-06-14T16:39:24.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option will vest in their entirety twelve months after June 13, 2024, subject to the Reporting Person's continued service as a director."}],"balance_after":30000,"derivative":{"exercise_price":2.99,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001562180-24-005079","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218024005079/primarydocument.xml","form_type":"4"}},{"id":1478552,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Flowers Cynthia Louise","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-14T16:39:24.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests in its entirety twelve months after June 13, 2024, subject to the Reporting Person's continued service as a director. The Reporting Person has elected to defer vesting of these shares pursuant to the G1 Therapeutics, Inc. Deferred Compensation Plan for Non-Employee Directors.  The RSUs will vest upon termination of the Reporting Person's service as a Director on the Company's Board."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of Issuer common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents (i) 15,889 shares of common stock; (ii) 10,000 RSUs from award granted on June 15, 2023; and (iii) 10,000 RSUs from award granted on June 13, 2024."}],"balance_after":35889,"source":{"system":"sec-edgar","filing":"0001562180-24-005079","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218024005079/primarydocument.xml","form_type":"4"}},{"id":1681153,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Flowers Cynthia Louise","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-11T21:05:37.000Z","date":"2024-01-09","kind":"grant","planned":false,"acquired":true,"shares":19480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 19,480  restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 9, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 19,480 unvested restricted stock units."}],"balance_after":49201,"source":{"system":"sec-edgar","filing":"0001741455-24-000002","document":"wk-form4_1705007128.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000174145524000002/wk-form4_1705007128.xml","form_type":"4"}},{"id":1851494,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Flowers Cynthia Louise","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-06-16T16:07:09.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option will vest in their entirety twelve months after June 15, 2023, subject to the Reporting Person's continued service as a director."}],"balance_after":30000,"derivative":{"exercise_price":2.83,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001562180-23-005271","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218023005271/primarydocument.xml","form_type":"4"}},{"id":1851493,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Flowers Cynthia Louise","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T16:07:09.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests in its entirety twelve months after June 15, 2023, subject to the Reporting Person's continued service as a director. The Reporting Person has elected to defer vesting of these shares pursuant to the G1 Therapeutics, Inc. Deferred Compensation Plan for Non-Employee Directors.  The RSUs will vest upon termination of the Reporting Person's service as a Director on the Company's Board."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of Issuer common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents (i) 5,889 shares of common stock; (ii) 10,000 RSUs from award granted on June 23, 2022; and (iii) 10,000 RSUs from award granted on June 15, 2023."}],"balance_after":25889,"source":{"system":"sec-edgar","filing":"0001562180-23-005271","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218023005271/primarydocument.xml","form_type":"4"}},{"id":2057068,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Flowers Cynthia Louise","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-11T21:15:48.000Z","date":"2023-01-09","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 20,000 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 9, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 24,362 unvested restricted stock units."}],"balance_after":29721,"source":{"system":"sec-edgar","filing":"0001741455-23-000002","document":"wf-form4_167347173416107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000174145523000002/wf-form4_167347173416107.xml","form_type":"4"}},{"id":2221821,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Flowers Cynthia Louise","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-06-24T16:51:14.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option will vest in their entirety twelve months after June 23, 2022, subject to the Reporting Person's continued service as a director."}],"balance_after":30000,"derivative":{"exercise_price":5.3,"expiration_date":"2032-06-23","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001562180-22-005351","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218022005351/primarydocument.xml","form_type":"4"}},{"id":2221820,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Flowers Cynthia Louise","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-24T16:51:14.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests in its entirety twelve months after June 23, 2022, subject to the Reporting Person's continued service as a director."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of Issuer common stock"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents 5,889 shares of common stock and 10,000 restricted stock units"}],"balance_after":15889,"source":{"system":"sec-edgar","filing":"0001562180-22-005351","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218022005351/primarydocument.xml","form_type":"4"}},{"id":2437211,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Flowers Cynthia Louise","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-12T21:10:28.000Z","date":"2022-01-10","kind":"grant","acquired":true,"shares":65430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 65,430 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 10, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 103,165 unvested restricted stock units."}],"balance_after":145847,"source":{"system":"sec-edgar","filing":"0001741455-22-000002","document":"wf-form4_164202181534309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000174145522000002/wf-form4_164202181534309.xml","form_type":"4"}},{"id":2519104,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Flowers Cynthia Louise","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-11-09T17:41:38.000Z","date":"2021-11-09","kind":"disposition_to_issuer","acquired":false,"shares":96975,"price":5.92,"value":574092.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the payment per share of Common Stock received in exchange for the cancellation of each Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Merger, all unvested stock options (\"Options\") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option."}],"balance_after":0,"derivative":{"exercise_price":3.58,"expiration_date":"2031-05-12","underlying":"Common Stock, par value $0.001","underlying_shares":96975},"source":{"system":"sec-edgar","filing":"0001104659-21-136411","document":"tm2131118-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1557142/000110465921136411/tm2131118-10_4seq1.xml","form_type":"4"}},{"id":2519103,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Flowers Cynthia Louise","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-11-09T17:41:38.000Z","date":"2021-11-09","kind":"disposition_to_issuer","acquired":false,"shares":85034,"price":5.06,"value":430272.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the payment per share of Common Stock received in exchange for the cancellation of each Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Merger, all unvested stock options (\"Options\") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option."}],"balance_after":0,"derivative":{"exercise_price":4.44,"expiration_date":"2030-05-13","underlying":"Common Stock, par value $0.001","underlying_shares":85034},"source":{"system":"sec-edgar","filing":"0001104659-21-136411","document":"tm2131118-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1557142/000110465921136411/tm2131118-10_4seq1.xml","form_type":"4"}},{"id":2519102,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Flowers Cynthia Louise","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-11-09T17:41:38.000Z","date":"2021-11-09","kind":"disposition_to_issuer","acquired":false,"shares":100000,"price":7.21,"value":721000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the payment per share of Common Stock received in exchange for the cancellation of each Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Merger, all unvested stock options (\"Options\") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option."}],"balance_after":0,"derivative":{"exercise_price":2.29,"expiration_date":"2029-05-15","underlying":"Common Stock, par value $0.001","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-21-136411","document":"tm2131118-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1557142/000110465921136411/tm2131118-10_4seq1.xml","form_type":"4"}},{"id":2519101,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Flowers Cynthia Louise","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-11-09T17:41:38.000Z","date":"2021-11-09","kind":"disposition_to_issuer","acquired":false,"shares":64935,"price":7.23,"value":469480.05,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the payment per share of Common Stock received in exchange for the cancellation of each Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Merger, all unvested stock options (\"Options\") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option."}],"balance_after":0,"derivative":{"exercise_price":2.27,"expiration_date":"2029-01-22","underlying":"Common Stock, par value $0.001","underlying_shares":64935},"source":{"system":"sec-edgar","filing":"0001104659-21-136411","document":"tm2131118-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1557142/000110465921136411/tm2131118-10_4seq1.xml","form_type":"4"}},{"id":2519100,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Flowers Cynthia Louise","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-09T17:41:38.000Z","date":"2021-11-09","kind":"disposition_to_issuer","acquired":false,"shares":10850,"price":9.5,"value":103075.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed pursuant to the acquisition by Sanofi of the entire issued share capital of Issuer on November 9, 2021 by means of a plan of merger (the \"Merger\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-21-136411","document":"tm2131118-10_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1557142/000110465921136411/tm2131118-10_4seq1.xml","form_type":"4"}},{"id":2519099,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Flowers Cynthia Louise","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-09T17:41:38.000Z","date":"2021-11-08","kind":"gift","acquired":false,"shares":20150,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10850,"source":{"system":"sec-edgar","filing":"0001104659-21-136411","document":"tm2131118-10_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557142/000110465921136411/tm2131118-10_4seq1.xml","form_type":"4"}},{"id":2660153,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Schwalm Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2021-06-21T16:25:01.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":19620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option will vest in their entirety twelve months after June 17, 2021, subject to the Reporting Person's continued service as a director."}],"balance_after":19620,"derivative":{"exercise_price":21.97,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":19620},"source":{"system":"sec-edgar","filing":"0001562180-21-004397","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218021004397/primarydocument.xml","form_type":"4"}},{"id":2660152,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Schwalm Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-21T16:25:01.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":4389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests in its entirety twelve months after June 17, 2021, subject to the Reporting Person's continued service as a director."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of Issuer common stock"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents 1,500 shares of common stock and 4,389 restricted stock units"}],"balance_after":5889,"source":{"system":"sec-edgar","filing":"0001562180-21-004397","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218021004397/primarydocument.xml","form_type":"4"}},{"id":2714015,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Schwalm Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-13T16:17:55.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":96975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in full on the first anniversary of the grant date, or May 12, 2022"}],"balance_after":96975,"derivative":{"exercise_price":3.58,"expiration_date":"2031-05-12","underlying":"Common stock","underlying_shares":96975},"source":{"system":"sec-edgar","filing":"0001593968-21-001315","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557142/000159396821001315/primary_01.xml","form_type":"4"}},{"id":2910144,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Schwalm Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-12T23:20:29.000Z","date":"2021-01-11","kind":"grant","acquired":true,"shares":37735,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 37,735 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 11, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 60,117 unvested restricted stock units."}],"balance_after":80417,"source":{"system":"sec-edgar","filing":"0001741455-21-000003","document":"wf-form4_161049361662902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000174145521000003/wf-form4_161049361662902.xml","form_type":"4"}},{"id":3111448,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Schwalm Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-12T16:42:04.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option will vest in their entirety twelve months after June 11, 2020, subject to the Reporting Person's continued service as a director."}],"balance_after":20000,"derivative":{"exercise_price":17.59,"expiration_date":"2030-06-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-036308","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000120919120036308/doc4.xml","form_type":"4"}},{"id":3148504,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Schwalm Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-14T16:27:37.000Z","date":"2020-05-13","kind":"grant","acquired":true,"shares":85034,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option becomes vested and exercisable on May 13, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Only represents derivative securities of this class."}],"balance_after":85034,"derivative":{"exercise_price":4.44,"exercise_date":"2021-05-13","expiration_date":"2030-05-13","underlying":"Common stock, $0.001 par value","underlying_shares":85034},"source":{"system":"sec-edgar","filing":"0001593968-20-001175","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557142/000159396820001175/primary_01.xml","form_type":"4"}},{"id":3212912,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Schwalm Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.001","published_at":"2020-03-12T17:57:47.000Z","date":"2020-03-12","kind":"purchase","acquired":true,"shares":21693,"price":3.24,"value":70285.32,"ownership":{"direct":true},"balance_after":31000,"source":{"system":"sec-edgar","filing":"0001593968-20-000754","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1557142/000159396820000754/primary_01.xml","form_type":"4"}},{"id":3212911,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Schwalm Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.001","published_at":"2020-03-12T17:57:47.000Z","date":"2020-03-12","kind":"purchase","acquired":true,"shares":9307,"price":3.235,"value":30108.145,"ownership":{"direct":true},"balance_after":9307,"source":{"system":"sec-edgar","filing":"0001593968-20-000754","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557142/000159396820000754/primary_01.xml","form_type":"4"}},{"id":3312105,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Schwalm Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-01-14T21:18:17.000Z","date":"2020-01-13","kind":"grant","acquired":true,"shares":18292,"price":3.28,"value":59997.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 18,292 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 13, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 18,292 unvested restricted stock units."}],"balance_after":42682,"source":{"system":"sec-edgar","filing":"0001741455-20-000002","document":"wf-form4_157903667938717.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000174145520000002/wf-form4_157903667938717.xml","form_type":"4"}},{"id":3489086,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Schwalm Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-14T16:31:43.000Z","date":"2019-06-12","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option will vest in their entirety twelve months after June 12, 2019, subject to the Reporting Person's continued service as a director."}],"balance_after":20000,"derivative":{"exercise_price":18.47,"expiration_date":"2029-06-12","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-19-037144","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000120919119037144/doc4.xml","form_type":"4"}},{"id":3523215,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Schwalm Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-16T16:51:27.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":100000,"price":2.29,"value":229000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option becomes vested and exercisable on May 15, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Only represents derivative securities of this class."}],"balance_after":164935,"derivative":{"exercise_price":2.29,"exercise_date":"2020-05-15","expiration_date":"2029-05-15","underlying":"Common stock, $0.001 par value","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001593968-19-001124","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557142/000159396819001124/primary_01.xml","form_type":"4"}},{"id":3689116,"issuer":{"id":133686,"kind":"organization","name":"Kadmon Holdings, Inc.","symbol":"KDMN"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Schwalm Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2019-01-23T16:27:51.000Z","date":"2019-01-22","kind":"grant","acquired":true,"shares":64935,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes vested and exercisable in three equal annual installments over 3 years from January 22, 2019, the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Only represents derivative securities of this class."}],"balance_after":64935,"derivative":{"exercise_price":2.27,"expiration_date":"2029-01-22","underlying":"Common Stock, par value $0.001","underlying_shares":64935},"source":{"system":"sec-edgar","filing":"0001593968-19-000195","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557142/000159396819000195/primary_01.xml","form_type":"4"}},{"id":3695045,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Schwalm Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-01-16T21:10:38.000Z","date":"2019-01-14","kind":"grant","acquired":true,"shares":12121,"price":4.95,"value":59998.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 12,121 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 14, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 24,390 unvested restricted stock units."}],"balance_after":24390,"source":{"system":"sec-edgar","filing":"0001741455-19-000003","document":"wf-form4_154767302188946.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000174145519000003/wf-form4_154767302188946.xml","form_type":"4"}},{"id":3717376,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Schwalm Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-27T16:59:45.000Z","date":"2018-12-26","kind":"purchase","acquired":true,"shares":1420,"price":18.4482,"value":26196.444,"ownership":{"direct":true},"balance_after":1500,"source":{"system":"sec-edgar","filing":"0001562180-18-005114","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018005114/primarydocument.xml","form_type":"4"}},{"id":3771135,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Schwalm Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-11-08T21:19:10.000Z","date":"2018-11-07","kind":"grant","acquired":true,"shares":12269,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents 12,269 shares of restricted stock units granted under the 2018 Equity Incentive Compensation Plan. The shares of restricted stock units will vest in annual installments over a three-year period with the initial vesting on November 7, 2019."}],"balance_after":12269,"derivative":{"exercise_price":0,"exercise_date":"2019-11-07","expiration_date":"2028-11-07","underlying":"Common Stock","underlying_shares":12269},"source":{"system":"sec-edgar","filing":"0001741455-18-000014","document":"wf-form4_154171193038892.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000174145518000014/wf-form4_154171193038892.xml","form_type":"4"}},{"id":3897993,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":69465,"kind":"person","name":"Flowers Cynthia Louise","position":1,"cik":"0001741455","reported_name":"Schwalm Cynthia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-11T11:52:35.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option will vest in equal monthly installments over a period of three years, subject to the Reporting Person's continued service as a director."}],"balance_after":20000,"derivative":{"exercise_price":38.39,"expiration_date":"2028-06-07","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-18-036861","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000120919118036861/doc4.xml","form_type":"4"}}]}